Anticancer peptides
(ACPs) are promising antitumor resources, and
developing acid-activated ACPs as more effective and selective antitumor
drugs would represent new progress in cancer therapy. In this study,
we designed a new class of acid-activated hybrid peptides LK-LE by
altering the charge shielding position of the anionic binding partner
LE based on the cationic ACP LK and investigated their pH response,
cytotoxic activity, and serum stability, in hoping to achieve a desirable
acid-activatable ACP. As expected, the obtained hybrid peptides could
be activated and exhibit a remarkable antitumor activity by rapid
membrane disruption at acidic pH, whereas its killing activity could
be alleviated at normal pH, showing a significant pH response compared
with LK. Importantly, this study found that the peptide LK-LE3 with
the charge shielding in the N-terminal of LK displayed notably low
cytotoxicity and more stability, demonstrating that the position of
charge masking is extremely important for the improvement of peptide
toxicity and stability. In short, our work opens a new avenue to design
promising acid-activated ACPs as potential targeting agents for cancer
treatment.